rhASA - Dose Level 1
rhASA-01
Phase 1 mab completed
Quick answer
rhASA - Dose Level 1 for Metachromatic Leukodystrophy (MLD) is a Phase 1 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Metachromatic Leukodystrophy (MLD)
- Phase
- Phase 1
- Modality
- mab
- Status
- completed